Showing results (1-10 of 506) with videos related to
Sort By:
Pageof 51
Clinical Advances in Hematology & Oncology : H&O|February 17, 2021
Early intervention in asymptomatic chronic lymphocytic leukemiaEli Muchtar, Neil E Kay, Sameer A ParikhClinical Advances in Hematology & Oncology : H&O|June 5, 2014
Monoclonal B-cell lymphocytosis: update on diagnosis, clinical outcome, and counselingSameer A Parikh, Neil E Kay, Tait D ShanafeltResearch Square|October 14, 2024
Profound deficiencies in mature blood and bone marrow progenitor dendritic cells in Chronic Lymphocyticcytic Leukemia patientsBaustin M Welch, Sameer A Parikh, Neil E Kay, et al.Leukemia|June 26, 2025
Profound phenotypic deficiencies in mature blood and bone marrow progenitor dendritic cells in chronic lymphocytic leukemia patientsBaustin M Welch, Sameer A Parikh, Neil E Kay, et al.Blood Reviews|February 13, 2022
CLL update 2022: A continuing evolution in careNeil E Kay, Paul J Hampel, Daniel L Van Dyke, et al.Experimental Hematology|May 7, 2022
Serum B-Cell maturation antigen is an independent prognostic marker in previously untreated chronic lymphocytic leukemiaCamilia M Soof, Tanya M Spektor, Sameer A Parikh, et al.Haematologica|June 15, 2019
Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single centerYucai Wang, Marcella A Tschautscher, Kari G Rabe, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 2, 2025
A pilot study to determine the feasibility and safety of pharmacist and nurse driven management of venetoclax ramp-up in patients with chronic lymphocytic leukemiaRachel J Bailen, Monica I Aasum, Linda M Tamminga, et al.Therapeutic Advances in Hematology|August 6, 2016
Elotuzumab: the first approved monoclonal antibody for multiple myeloma treatmentHila Magen, Eli MuchtarPageof 51